Chemical Structure : OTS-964
CAS No.: 1338545-07-5
Catalog No.: PC-43047Not For Human Use, Lab Use Only.
OTS-964 is a dimethylated derivative of OTS514 and potent, selective TOPK inhibitor with IC50 of 28 nM, exhibits excellent in vivo efficacy with liposomal formulation.
Packing | Price | Stock | Quantity |
---|---|---|---|
5 mg | $88 | In stock | |
10 mg | $128 | In stock | |
25 mg | $198 | In stock | |
50 mg | Get quote | ||
100 mg | Get quote |
Bulk size, bulk discount!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
OTS-964 is a dimethylated derivative of OTS514 and potent, selective TOPK inhibitor with IC50 of 28 nM, exhibits excellent in vivo efficacy with liposomal formulation.
OTS-964 inhibits the growth of TOPK-positive cells with low IC50 values (A549 IC50=31 nM), decreases autophosphorylation of TOPK (Thr9), as well as phosphorylation of histone H3 (Ser10), in both T47D and LU-99 cells.
The liposomal OTS964 causes complete regression of tumors without any detectable toxicity in the xenograft models.
M.Wt | 428.9748 | |
Formula | C23H25ClN2O2S | |
Appearance | Solid | |
Storage |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
Thieno[2,3-c]quinolin-4(5H)-one, 9-[4-[(1R)-2-(dimethylamino)-1-methylethyl]phenyl]-8-hydroxy-6-methyl-, hydrochloride (1:1) |
1. Matsuo Y, et al. Sci Transl Med. 2014 Oct 22;6(259):259ra145.
2. Ikeda Y, et al. Clin Cancer Res. 2016 Dec 15;22(24):6110-6117.
3. Pirovano G, et al. Br J Cancer. 2017 Aug 8;117(4):503-512.
4. Sugimori M, et al. Oncotarget. 2017 Dec 9;9(3):3043-3059.
Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright